Processa Pharmaceuticals, Inc. (PCSA)
2.02
-0.14
(-6.48%)
USD |
NASDAQ |
Sep 09, 10:53
Processa Pharmaceuticals Shareholders Equity (Quarterly) : -0.3173M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3173M |
| March 31, 2026 | 2.541M |
| December 31, 2025 | 5.577M |
| September 30, 2025 | 5.834M |
| June 30, 2025 | 6.107M |
| March 31, 2025 | 3.527M |
| December 31, 2024 | 1.696M |
| September 30, 2024 | 3.721M |
| June 30, 2024 | 6.024M |
| March 31, 2024 | 8.883M |
| December 31, 2023 | 4.989M |
| September 30, 2023 | 7.168M |
| June 30, 2023 | 9.160M |
| March 31, 2023 | 10.14M |
| December 31, 2022 | 7.471M |
| September 30, 2022 | 17.24M |
| June 30, 2022 | 20.08M |
| March 31, 2022 | 23.24M |
| December 31, 2021 | 25.49M |
| September 30, 2021 | 27.21M |
| June 30, 2021 | 29.24M |
| March 31, 2021 | 31.34M |
| December 31, 2020 | 22.94M |
| September 30, 2020 | 5.527M |
| June 30, 2020 | 6.593M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.234M |
| December 31, 2019 | 8.012M |
| September 30, 2019 | 8.671M |
| June 30, 2019 | 9.906M |
| March 31, 2019 | 10.81M |
| December 31, 2018 | 11.50M |
| September 30, 2018 | 12.31M |
| June 30, 2018 | 13.11M |
| March 31, 2018 | 7.276M |
| December 31, 2017 | |
| September 30, 2017 | -0.0351M |
| June 30, 2017 | -2.491M |
| March 31, 2017 | -2.437M |
| December 31, 2016 | -2.351M |
| September 30, 2016 | -2.250M |
| June 30, 2016 | -2.170M |
| March 31, 2016 | -2.118M |
| December 31, 2015 | |
| September 30, 2015 | -1.618M |
| June 30, 2015 | -1.320M |
| March 31, 2015 | 0.7018M |
| December 31, 2014 | 1.208M |
| September 30, 2014 | -0.1168M |
| June 30, 2014 | 0.623M |
| March 31, 2014 | 1.030M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.070M |
| Total Liabilities (Quarterly) | 2.387M |
| Current Ratio | 0.8657 |
| Net Debt Paydown Yield | 0.19% |